PT - JOURNAL ARTICLE AU - Ott, Isabel M. AU - Strine, Madison S. AU - Watkins, Anne E. AU - Boot, Maikel AU - Kalinich, Chaney C. AU - Harden, Christina A. AU - Vogels, Chantal B.F. AU - Casanovas-Massana, Arnau AU - Moore, Adam J. AU - Muenker, M. Catherine AU - Nakahata, Maura AU - Tokuyama, Maria AU - Nelson, Allison AU - Fournier, John AU - Bermejo, Santos AU - Campbell, Melissa AU - Datta, Rupak AU - , AU - Cruz, Charles S. Dela AU - Farhadian, Shelli F. AU - Ko, Albert I. AU - Iwasaki, Akiko AU - Grubaugh, Nathan D. AU - Wilen, Craig B. AU - Wyllie, Anne L. TI - Simply saliva: stability of SARS-CoV-2 detection negates the need for expensive collection devices AID - 10.1101/2020.08.03.20165233 DP - 2020 Jan 01 TA - medRxiv PG - 2020.08.03.20165233 4099 - http://medrxiv.org/content/early/2020/08/04/2020.08.03.20165233.short 4100 - http://medrxiv.org/content/early/2020/08/04/2020.08.03.20165233.full AB - Most currently approved strategies for the collection of saliva for COVID-19 diagnostics require specialized tubes containing buffers promoted for the stabilization of SARS-CoV-2 RNA and virus inactivation. Yet many of these are expensive, in limited supply, and not necessarily validated specifically for viral RNA. While saliva is a promising sample type as it can be reliably self-collected for the sensitive detection of SARS-CoV-2, the expense and availability of these collection tubes are prohibitive to mass testing efforts. Therefore, we investigated the stability of SARS-CoV-2 RNA and infectious virus detection from saliva without supplementation. We tested RNA stability over extended periods of time (2-25 days) and at temperatures representing at-home storage and elevated temperatures which might be experienced when cold chain transport may be unavailable. We found SARS-CoV-2 RNA in saliva from infected individuals is stable at 4°C, room temperature (∼19°C), and 30°C for prolonged periods and found limited evidence for viral replication in stored saliva samples. This work demonstrates that expensive saliva collection options involving RNA stabilization and virus inactivation buffers are not always needed, permitting the use of cheaper collection options. Affordable testing methods are urgently needed to meet current testing demands and for continued surveillance in reopening strategies.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the Huffman Family Donor Advised Fund, Fast Grant funding support from the Emergent Ventures at the Mercatus Center, George Mason University, the Yale Institute for Global Health, and the Beatrice Kleinberg Neuwirth Fund. CBFV is supported by NWO Rubicon 019.181EN.004. CBW is supported by NIH K08 AI128043, the Burroughs Wellcome Fund, and the Ludwig Family Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All study participants were enrolled and sampled in accordance to the Yale University HIC-approved protocol #2000027690. Demographics, clinical data and samples were collected after the study participant had acknowledged that they had understood the study protocol and signed the informed consent. All participant information and samples were collected in association with non-individually identifiable study identifiers.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available from the corresponding author, [ALW], upon reasonable request.